what is semaglutide injection for weight loss FDA approves obesity drug that helped people cut 15% Semaglutide: A Breakthrough in Personalized

This dual GIP/GLP-1 receptor agonist, approved by the FDA for type 2 diabetes and chronic weight management, may cause dizziness through several mechanisms including dehydration from gastrointestinal side effects, medication interactions affecting blood pressure, hypoglycemia when combined with insulin or sulfonylureas, and orthostatic hypotension related to weight loss

Live Chat Support Good Available in the patient portal only, with very inconsistent response times

We want to partner with you to achieve your health and wellness goals

One caveat

Protective strategies include consuming 1.21.6 g protein per kg ideal body weight daily and engaging in resistance training at least twice weekly